Clinical Trial Update: Adapted Fluence Settings for Corneal Collagen Cross-linking in Mild to Moderate Progressive Keratoconus [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes adapted fluence settings for corneal collagen cross-linking in mild-to-moderate progressive keratoconus across Phase 1 and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Keratoconus | Phase 1, Phase 2 | Status: UNKNOWN